ABCG1 and SREBF1 demonstrated hypermethylation, whereas LOXL2, SLC1A5, and TXNIP demonstrated hypomethylation in patients with T2DM compared with healthy controls. The gene discussed is ABCG1; the disease is type 2 diabetes mellitus.